Surge in Market Capitalisation Six of Top10 Firms Add Rs 74111 Crore Reliance Emerges as Biggest Gainer AIRelated Layoffs Not Necessarily a Boost for Stocks UK Government Commits 120 Million to Support Ceramics Industry Says Trade Body Gold Prices Flat as Investors Eye USIran Peace Negotiations UnitedHealth Group UNH Receives Price Target Upgrade as Managed Care Sector Shows Margin Recovery Potential Subramanian Swamy Calls for Ban on Cement Imports from Pakistan Citing Security Risks Reliance Global Group Q1 2023 Earnings Surprise Profitability Defies Estimates TECX Q1 2026 Earnings WiderthanExpected Loss Amid Pipeline Focus Stock Edges Higher NWE Q1 2026 Earnings EPS Beats Estimates by 69 Amid Solid Operational Performance INLX Q1 2026 Earnings Significant EPS Miss Highlights Operational Headwinds YSG Q4 2025 Earnings Positive EPS but Revenue Transparency Remains Limited MGEE Q1 2026 Earnings EPS Surpasses Estimates on Strong Utility Performance General Motors GM Surges Over 5 as Investor Sentiment Strengthens American Healthcare REIT AHR Dips 138 Support and Resistance in Focus AllianceBernstein Global High Income Fund AWF Edges Higher as Income Seekers Return BUUU Group Limited BUUU Slides 891 as Selling Pressure Intensifies ACI Worldwide ACIW Inches Higher Amid Consolidation Key Levels in Focus Major Tech Firms Launch 125 Million Semiconductor Research Hub at UCLA IDCC Q1 2026 Earnings EPS Surges Past Estimates on Strong Licensing Revenue Stock Declines Apex Treasury Warrants APXTW Slip to 023 Trading Range Tightens Amid Thin Volume Evertec Inc EVTC Q1 2026 Earnings EPS Miss Sends Shares Lower Amid WeakerThanExpected Bottom Line HTB Q1 2026 Earnings EPS Surges Past Estimates with a 20 Beat Crown Castle CCI Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower ENIC Q4 2025 Earnings Earnings Beat Estimates Amid Challenging Market Conditions enCore Energy Corp EU Q1 2026 Earnings Surprise Profit Driven by Strong Uranium Sales TBPH Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline IBRX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress